Thessalonki, 18 – 21/04/2024
Makedonia Palace
IASIS PHARMA participated in the 19th International Congress of Dermatology & Venereology held on April 18-21, 2024, at the “Makedonia Palace” hotel in Thessaloniki.
The conference was organized by the Hellenic Dermatology & Venereology Society.
Greek Dermatologists attended the congress and had the chance to visit IASIS PHARMA exhibition stand and got informed of 3 important IASIS Dermatological products:
- Isotroin®/ Isotretinoin (at the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg is added to the range of the other Isotroin® strengths (10mg, 20mg & 40mg).
- Combi®, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.
- Modiwart®/Ιmiquimod (12,5mg/sach), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.
